Literature DB >> 27853825

Clindamycin hydrochloride and clindamycin phosphate: two drugs or one? A retrospective analysis of a spontaneous reporting system.

Haona Li1, Jianxiong Deng2, Zhihua Yue3, Yiexiang Zhang2, He Sun4,5, Xuequn Ren6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27853825     DOI： 10.1007/s00228-016-2161-7

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  9 in total

1.  A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the WHO international database.

Authors:  M Lindquist; M Ståhl; A Bate; I R Edwards; R H Meyboom
Journal:  Drug Saf       Date:  2000-12       Impact factor: 5.606

2.  Use of measures of disproportionality in pharmacovigilance: three Dutch examples.

Authors:  Antoine C G Egberts; Ronald H B Meyboom; Eugène P van Puijenbroek
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 3.  Clindamycin as an antimalarial drug: review of clinical trials.

Authors:  Bertrand Lell; Peter G Kremsner
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

Review 4.  The reporting odds ratio and its advantages over the proportional reporting ratio.

Authors:  Kenneth J Rothman; Stephan Lanes; Susan T Sacks
Journal:  Pharmacoepidemiol Drug Saf       Date:  2004-08       Impact factor: 2.890

Review 5.  The investigation of hematuria.

Authors:  Priscilla Kincaid-Smith; Kenneth Fairley
Journal:  Semin Nephrol       Date:  2005-05       Impact factor: 5.299

6.  Drug-versus-drug adverse event rate comparisons: a pilot study based on data from the US FDA Adverse Event Reporting System.

Authors:  Alan M Hochberg; Ronald K Pearson; Donald J O'Hara; Stephanie J Reisinger
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

7.  Detecting drug-herbal interaction using a spontaneous reporting system database: an example with benzylpenicillin and qingkailing injection.

Authors:  Haona Li; Jianxiong Deng; Zhihua Yue; Yiexiang Zhang; He Sun
Journal:  Eur J Clin Pharmacol       Date:  2015-07-11       Impact factor: 2.953

8.  A computerized system for detecting signals due to drug-drug interactions in spontaneous reporting systems.

Authors:  Yifeng Qian; Xiaofei Ye; Wenmin Du; Jingtian Ren; Yalin Sun; Hainan Wang; Baozhang Luo; Qingbin Gao; Meijing Wu; Jia He
Journal:  Br J Clin Pharmacol       Date:  2010-01       Impact factor: 4.335

9.  Cutaneous adverse reactions to clindamycin: results of skin tests and oral exposure.

Authors:  K Lammintausta; R Tokola; K Kalimo
Journal:  Br J Dermatol       Date:  2002-04       Impact factor: 9.302
  9 in total
  1 in total

1.  Injectable Platelet-Rich Fibrin as a Drug Carrier Increases the Antibacterial Susceptibility of Antibiotic-Clindamycin Phosphate.

Authors:  Karina Egle; Ingus Skadins; Andra Grava; Lana Micko; Viktors Dubniks; Ilze Salma; Arita Dubnika
Journal:  Int J Mol Sci       Date:  2022-07-03       Impact factor: 6.208
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.